Chugai Pharmaceutical Co. Ltd.
CHGCY | OTC
$21.03
-$0.43 (-2.00%)
Sep 24, 2026, 3:00 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 471.37B | 452.2B | 434.01B | 397.16B | 395.44B | 410.15B | 387.32B | 386.96B | 397.49B | 398.33B | 436.21B | 506.72B | 492.82B | 488.49B | 575.88B | 513B | 540.1B | 502.45B | 376.3B | 329.77B | 293.35B | 300.31B |
Depreciation & Amortization | 40.5B | 40.9B | 32.5B | 51.07B | 31.67B | 31.67B | 31.67B | 2.8B | 2.7B | 2.7B | 2.8B | 1.8B | 2B | 1.9B | 1.7B | 31.97B | 31.87B | 32.77B | 32.47B | 31.98B | 31.58B | 30.38B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -83.3B | -63.75B | -79.65B | -8.33B | 54.2B | -32.2B | -28.84B | -25.26B | -65.9B | 50.55B | 130.63B | -80.98B | -75.84B | -25.96B | -183.31B | -46.09B | -48.13B | -156.45B | -83.12B | -29.86B | -15.94B | 10.54B |
Other Non-Cash Items | 24.99B | 16.17B | 2.59B | -28.09B | -17.21B | 5.14B | 58.19B | 55.99B | -6.87B | -68.13B | -159.36B | -168.82B | -166.37B | -165.12B | -150.15B | -132.81B | -101.28B | -73.14B | -46.02B | -75B | -56.32B | -94.65B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -83.3B | -63.75B | -79.65B | -8.33B | 54.2B | -32.2B | -28.84B | -25.26B | -65.9B | 50.55B | 130.63B | -80.98B | -75.84B | -25.96B | -183.31B | -46.09B | -48.13B | -156.45B | -83.12B | -29.86B | -15.94B | 10.54B |
Operating Cash Flow | 453.57B | 445.51B | 389.45B | 411.8B | 464.1B | 414.75B | 448.33B | 420.5B | 327.42B | 383.44B | 410.28B | 258.71B | 252.61B | 299.32B | 244.11B | 366.07B | 422.55B | 305.63B | 279.63B | 256.89B | 252.66B | 246.57B |
Capital Expenditures | -48.64B | -66.87B | -76.27B | -59.22B | -66.77B | -60.44B | -50.87B | -68.77B | -60.61B | -59.6B | -74.26B | -68.05B | -67.6B | -61.64B | -71.24B | -67.08B | -83.32B | -77.76B | -72.87B | -76.02B | -58.26B | -80.99B |
Cash Acquisitions | 152M | 7.51B | 7.51B | 7.29B | 7.36B | n/a | n/a | 17.36B | 17.41B | 17.09B | 18.79B | 1.35B | 1.27B | 2.74B | 1.05B | 1.11B | 3.57B | 3.91B | 6.86B | 8.15B | 6.48B | 6.07B |
Purchase of Investments | -1.23T | -1.17T | -1.23T | -1.12T | -1.06T | -1.08T | -948.55B | -852.08B | -742.47B | -569.38B | -545.98B | -545.19B | -572.49B | -565.62B | -519B | -488.33B | -409.62B | -382.24B | -372.26B | -343.18B | -353.16B | -290.34B |
Sales Maturities Of Investments | 1.2T | 1.27T | 1.13T | 1.13T | 946.56B | 856.53B | 771.02B | 697.26B | 619.27B | 574.54B | 546.96B | 530.09B | 507.93B | 462.05B | 442.92B | 412.95B | 372.8B | 352.8B | 325.03B | 274.99B | 242.99B | 242.99B |
Other Investing Acitivies | 15M | n/a | 29M | 611M | 1.77B | 2.92B | 3.75B | 3.17B | 2.46B | 2.75B | 16.77B | 16.85B | 16.49B | 15.08B | 280M | 211M | -2.29B | -2.72B | -5.68B | -6.94B | -5.28B | -5.96B |
Investing Cash Flow | -108.67B | -4.98B | -204.87B | -59.57B | -190.68B | -284.04B | -228.69B | -205.98B | -165.69B | -34.6B | -37.73B | -64.95B | -114.39B | -147.38B | -145.99B | -141.15B | -118.86B | -106.01B | -118.93B | -143B | -167.23B | -128.23B |
Debt Repayment | n/a | n/a | -2.03B | -2.03B | -2.03B | -2.03B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -3.94B | -7M | -6M | -4M | -7M | -8M | -10M | -11M | -8M | -7M | -5M | -4M | -4M | -5M | -5M | -5M | -5M | -5M | -8M | -9M | -12M | -24M |
Dividend Paid | -447.5B | -448B | -299.42B | -299.83B | -161.6B | -161.7B | -133.25B | -133.33B | -131.28B | -131.19B | -131.59B | -131.65B | -128.3B | -128.43B | -138.22B | -138.12B | -125.07B | -124.76B | -98.64B | -98.54B | -90.4B | -90.39B |
Other Financial Acitivies | -9.01B | -8.65B | -6.14B | -5.56B | -5.69B | -5.84B | -7.82B | -8.06B | -7.94B | -7.82B | -7.87B | -7.91B | -7.87B | -7.84B | -7.66B | -8.43B | -8.55B | -8.7B | -9.08B | -8.52B | -8.51B | -8.58B |
Financial Cash Flow | -460.37B | -456.57B | -307.46B | -307.28B | -169.12B | -169.37B | -140.91B | -141.19B | -139.07B | -138.84B | -139.25B | -139.39B | -135.98B | -136.05B | -145.64B | -146.27B | -133.33B | -133.15B | -107.41B | -106.75B | -98.6B | -98.66B |
Net Cash Flow | -106.65B | -5.44B | -113.6B | 52.47B | 103.33B | -39.44B | 81.53B | 72.62B | 28.75B | 215.18B | 236.51B | 57.3B | 4.71B | 17.21B | -45.58B | 81.53B | 173.18B | 68.43B | 55.42B | 9.81B | -9.47B | 23.34B |
Free Cash Flow | 404.93B | 378.65B | 313.18B | 352.58B | 397.34B | 354.32B | 397.46B | 351.73B | 266.81B | 323.84B | 336.02B | 190.67B | 185.01B | 237.68B | 172.87B | 298.99B | 339.24B | 227.87B | 206.76B | 180.87B | 194.4B | 165.58B |
Adj. Free Cash Flow | 404.93B | 378.65B | 313.18B | 352.58B | 397.34B | 354.32B | 397.46B | 351.73B | 266.81B | 323.84B | 336.02B | 190.67B | 185.01B | 237.68B | 172.87B | 298.99B | 339.24B | 227.87B | 206.76B | 180.87B | 194.4B | 165.58B |
Maintenance CapEx | -13.71B | -40.54B | -35.12B | -33.82B | -30.2B | -6.33B | -15.48B | -33.7B | -33.7B | -38.94B | -38.11B | -19.89B | -28.81B | -29.22B | -19.66B | -19.66B | -10.75B | -2.15B | -31.89B | -31.89B | -32.37B | -55.16B |
Growth CapEx | -34.92B | -26.33B | -41.16B | -25.4B | -36.56B | -54.11B | -35.39B | -35.07B | -26.92B | -20.66B | -36.15B | -48.16B | -38.79B | -32.42B | -51.58B | -47.42B | -72.57B | -75.61B | -40.97B | -44.13B | -25.89B | -25.83B |
Owner Earnings | 439.85B | 404.98B | 354.33B | 377.98B | 433.9B | 408.43B | 432.85B | 386.8B | 293.72B | 344.51B | 372.17B | 238.82B | 223.8B | 270.1B | 224.45B | 346.41B | 411.8B | 303.48B | 247.73B | 225B | 220.29B | 191.41B |
Add to Watchlist
Select watchlists to add or remove CHGCY